The cost-utility of Sacral Neuromodulation versus Botulinum Toxin A for the treatment of refractory idiopathic overactive bladder (with urgency urinary incontinence) in Sweden

Research Type

Pure and Applied Science / Translational

Abstract Category

Overactive Bladder

Links
	Abstract 265
	New Research in Neuromodulation Scientific Podium Short Oral Session 20
	Thursday 8th October 2015
	12:15 - 12:22
	210AE
	Incontinence Neuromodulation Mathematical or statistical modelling Overactive Bladder Quality of Life (QoL)
	1. Synergus AB, 2. Medtronic
Presenter
E Elisabeth Reimer Medtronic
Abstract PDF Disclosure PDF Edit Abstract Abstract Centre